The Business Cocktail

Posted on


Payers block Kaléo’s expensive EpiPen challenger

TC settlement clears Endo from pay-for-delay liability; Watson, Allergan charged

Amgen hikes prices by single digits, with Enbrel matching AbbVie’s Humira boost

Baxter paying $18M to settle federal case over sterile plant failings

Source: The Business Cocktail

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s